The worlds of medical and biological research are abuzz with the promises offered by nanoparticles known as semiconductor quantum dots. These Quantum Dots (QDs) have unique optical and electronic properties that make them suitable for breakthrough treatments such as the detection and destruction of cancer cells.
Just released on the nanotechnology website AZoNano, is a comprehensive review of the latest literature and studies into Quantum Dots. The review by Sandeep Kumar Vashist, Rupinder Tewari, Ram Prakash Bajpai, Lalit Mohan Bharadwaj and Roberto Raiteri, researchers from a range of Italian and Indian universities and research organisations, has been released as part of AZoJono*, the open access AZo Journal of Nanotechnology Online.
With a focus on the use of QDs in cancer detection and treatment, the review includes a detailed examination of Quantum Dot advantages, their synthesis, properties and applications, toxic effects, use in imaging and analysis plus Quantum Dot drug delivery systems. The paper also outlines some early success in the detection and treatment of breast cancer.
The paper concludes with a quick look at what the future may hold for Quantum Dots in providing new insights into understanding the pathophysiology of cancer and real time imaging and screening of tumours.
The level of details provided in this valuable review paper could easily make up a chapter in an expensive text book. However, this paper is available to access free of charge in its entirety at http://www.azonano.com/Details.asp?ArticleID=1726
Dr. Ian Birkby | EurekAlert!
On track to heal leukaemia
18.01.2017 | Universitätsspital Bern
Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).
Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...
10.01.2017 | Event News
09.01.2017 | Event News
05.01.2017 | Event News
18.01.2017 | Life Sciences
18.01.2017 | Information Technology
18.01.2017 | Life Sciences